{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:12:28Z","timestamp":1792512748568,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.neuropharm.2025.110661","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T17:20:54Z","timestamp":1756401654000},"page":"110661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Astragaloside \u2163 improves neuroinflammation in Parkinson's disease by regulating amino acid metabolism and the PI3K-AKT signaling pathway"],"prefix":"10.1016","volume":"280","author":[{"given":"Lianmei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110661_bib1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.lfs.2019.04.040","article-title":"Astragaloside \u2163 exerts angiogenesis and cardioprotection after myocardial infarction via regulating PTEN\/PI3K\/Akt signaling pathway","volume":"227","author":"Cheng","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2025.110661_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150186","article-title":"Resveratrol mediated the proliferation and apoptosis of gastric cancer cells by modulating the PI3K\/Akt\/P53 signaling pathway","volume":"723","author":"Dong","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2025.110661_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2020.104478","article-title":"Astragaloside \u2163 regulates endoplasmic reticulum stress-mediated neuronal apoptosis in a murine model of Parkinson's disease via the lincRNA-p21\/CHOP pathway","volume":"115","author":"Ge","year":"2020","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.neuropharm.2025.110661_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2023.113721","article-title":"New insights into the role of berberine against 3-nitropropionic acid-induced striatal neurotoxicity: Possible role of BDNF-TrkB-PI3K\/Akt and NF-\u03baB signaling","volume":"175","author":"Gendy","year":"2023","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110661_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.148756","article-title":"CCN3\/NOV inhibition attenuates oxidative stress-induced apoptosis of mouse neural stem\/progenitor cells by blocking the activation of p38 MAPK: an in vitro study","volume":"1827","author":"Guo","year":"2024","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110661_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.freeradbiomed.2024.06.018","article-title":"Neuroprotective effects of chlorogenic acid: modulation of Akt\/Erk1\/2 signaling to prevent neuronal apoptosis in Parkinson's disease","volume":"222","author":"He","year":"2024","journal-title":"Free Radic. Biol. Med."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110661_bib7","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.3390\/ijms24108827","article-title":"Natural products as the potential to improve Alzheimer's and Parkinson's disease","volume":"24","author":"Kim","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110661_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mcn.2009.02.011","article-title":"NOV\/CCN3 promotes maturation of cerebellar granule neuron precursors","volume":"43","author":"Le Dr\u00e9au","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110661_bib9","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12272-019-01133-0","article-title":"Significant roles of neuroinflammation in Parkinson's disease: therapeutic targets for PD prevention","volume":"42","author":"Lee","year":"2019","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.neuropharm.2025.110661_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.648636","article-title":"PI3K\/AKT signal pathway: a target of natural products in the prevention and treatment of Alzheimer's disease and Parkinson's disease","volume":"12","author":"Long","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110661_bib11","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00213-023-06415-6","article-title":"18\u03b2-glycyrrhetinic acid ameliorates MPTP-induced neurotoxicity in mice through activation of microglial anti-inflammatory phenotype","volume":"240","author":"Luo","year":"2023","journal-title":"Psychopharmacology (Berl)."},{"issue":"16","key":"10.1016\/j.neuropharm.2025.110661_bib12","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.3390\/molecules28166118","article-title":"Pharmacological effects of astragaloside \u2163: a review","volume":"28","author":"Liang","year":"2023","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110661_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210324","article-title":"CCN3\/NOV regulates proliferation and neuronal differentiation in mouse hippocampal neural stem cells via the activation of the Notch\/PTEN\/AKT pathway","volume":"24","author":"Luan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.neuropharm.2025.110661_bib14","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.3390\/ijms21228421","article-title":"Neurodegeneration and inflammation-an interesting interplay in Parkinson's disease","volume":"21","author":"Marogianni","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110661_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6565396","article-title":"2020 natural products and their bioactive compounds: neuroprotective potentials against neurodegenerative diseases","author":"Mohd Sairazi","year":"2020","journal-title":"Evid Based Comp. Alternat. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110661_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2169\/internalmedicine.8940-21","article-title":"Recent advances in drug therapy for Parkinson's disease","volume":"62","author":"Murakami","year":"2023","journal-title":"Intern. Med."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110661_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3390\/metabo13030369","article-title":"Metabolomic footprint of disrupted energetics and amino acid metabolism in neurodegenerative diseases: perspectives for early diagnosis and monitoring of therapy","volume":"13","author":"Maszka","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.neuropharm.2025.110661_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ibror.2019.12.002","article-title":"Effect of valerenic acid on neuroinflammation in a MPTP-induced mouse model of Parkinson's disease","volume":"8","author":"Rodr\u00edguez-Cruz","year":"2019","journal-title":"IBRO Rep"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110661_bib19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/mp.54.3.184","article-title":"The expression of ccn3 (nov) RNA and protein in the rat central nervous system is developmentally regulated","volume":"54","author":"Su","year":"2001","journal-title":"Mol. Pathol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110661_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2019","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.neuropharm.2025.110661_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107900","article-title":"Neuroprotective effect of crocin against rotenone-induced Parkinson's disease in rats: interplay between PI3K\/Akt\/mTOR signaling pathway and enhanced expression of miRNA-7 and miRNA-221","volume":"164","author":"Salama","year":"2020","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110661_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e22800","article-title":"Astragaloside \u2163 promotes cerebral angiogenesis and neurological recovery after focal ischemic stroke in mice via activating PI3K\/Akt\/mTOR signaling pathway","volume":"9","author":"Shi","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.neuropharm.2025.110661_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148603","article-title":"Active ingredients of Chinese medicine with immunomodulatory properties: NF-\u03baB pathway and Parkinson's disease","volume":"1822","author":"Song","year":"2024","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110661_bib24","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3390\/ijms25021071","article-title":"The potentiality of natural products and herbal medicine as novel medications for Parkinson's disease: a promising therapeutic approach","volume":"25","author":"So","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110661_bib25","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.2147\/DDDT.S272355","article-title":"Astragaloside \u2163: an effective drug for the treatment of cardiovascular diseases","volume":"14","author":"Tan","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.neuropharm.2025.110661_bib26","first-page":"710","article-title":"Bear bile powder alleviates Parkinson's disease-like behavior in mice by inhibiting astrocyte-mediated neuroinflammation","volume":"21","author":"Wang","year":"2023","journal-title":"Chin. J. Nat. Med."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110661_bib27","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1039\/D2FO03030F","article-title":"Integrated transcriptomics, proteomics and metabolomics to identify biomarkers of astragaloside \u2163 against cerebral ischemic injury in rats","volume":"14","author":"Wei","year":"2023","journal-title":"Food Funct."},{"key":"10.1016\/j.neuropharm.2025.110661_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2024.112436","article-title":"LncRNA NEAT1 promotes MPP+ induced injury of PC12 cells and accelerates the progression of Parkinson's disease in mice through FUS mediated inhibition of PI3K\/AKT\/mTOR signalling pathway","volume":"191","author":"Wang","year":"2024","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.neuropharm.2025.110661_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110262","article-title":"Metformin activates the PI3K\/AKT\/BDNF axis to attenuate postoperative cognitive dysfunction","volume":"265","author":"Wu","year":"2025","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110661_bib30","first-page":"5569","article-title":"Neuroprotective effects of astragaloside \u2163 on Parkinson disease models of mice and primary astrocytes","volume":"14","author":"Xia","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.neuropharm.2025.110661_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9925561","article-title":"Astragaloside \u2163 alleviates cerebral ischemia-reperfusion injury through NLRP3 inflammasome-mediated pyroptosis inhibition via activating Nrf2","volume":"2021","author":"Xiao","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2025.110661_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.631501","article-title":"Astragaloside \u2163 protects 6-hydroxydopamine-induced SH-SY5Y cell model of Parkinson's disease via activating the JAK2\/STAT3 pathway","volume":"15","author":"Xu","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110661_bib33","article-title":"Terpenoid natural products exert neuroprotection via the PI3K\/Akt pathway","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110661_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.05.036","article-title":"Astragaloside \u2163 ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson's disease mouse model","volume":"75","author":"Yang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110661_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135227","article-title":"Astragaloside \u2163 alleviates the brain damage induced by subarachnoid hemorrhage via PI3K\/Akt signaling pathway","volume":"735","author":"Yang","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2025.110661_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101485","article-title":"Single nucleotide mutation changes the capability of CCN3 in osteosarcoma cell invasion and differentiation","volume":"24","author":"Yan","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.neuropharm.2025.110661_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114229","article-title":"Astragaloside \u2163: a promising natural neuroprotective agent for neurological disorders","volume":"159","author":"Yao","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2025.110661_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117628","article-title":"Piperine promotes PI3K\/AKT\/mTOR-mediated gut-brain autophagy to degrade \u03b1-Synuclein in Parkinson's disease rats","volume":"322","author":"Yu","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"17","key":"10.1016\/j.neuropharm.2025.110661_bib39","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.3390\/app11178155","article-title":"Metabolomic investigation of synergistic mechanism for fangfeng extract preventing LPS induced neuroinflammation in BV-2 microglia cells","volume":"11","author":"Zhu","year":"2021","journal-title":"Appl. Sci."},{"key":"10.1016\/j.neuropharm.2025.110661_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113955","article-title":"Epimedin B exerts neuroprotective effect against MPTP-induced mouse model of Parkinson's disease: GPER as a potential target","volume":"156","author":"Zhang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2025.110661_bib41","article-title":"Astragaloside \u2163 alleviates stroke-triggered early brain injury by modulating neuroinflammation and ferroptosis via the Nrf2\/HO-1 signaling pathway","volume":"38","author":"Zhang","year":"2023","journal-title":"Acta Cir. Bras."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:45:09Z","timestamp":1772815509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825003697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":41,"alternative-id":["S0028390825003697"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110661","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Astragaloside \u2163 improves neuroinflammation in Parkinson's disease by regulating amino acid metabolism and the PI3K-AKT signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110661"}}